Literature DB >> 25298836

Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder.

Israel Fernandez-Pineda1, David Marcilla2, Francisco Javier Downey-Carmona3, Sebastian Roldan1, Lucia Ortega-Laureano1, Jose Bernabeu-Wittel4.   

Abstract

The acronym FAVA (Fibro-Adipose Vascular Anomaly) has been recently given to a distinct vascular entity that is characterized by fibrofatty infiltration of muscle, unusual phlebectasia with pain, and contracture of the affected extremity. We report a new case of FAVA in a 10-year-old girl with pain in her right lower leg and equinus contracture. As in our case, FAVA typically presents in young females with calf involvement and limited ankle dorsiflexion with local pain. FAVA should be considered as a differential diagnosis when evaluating vascular anomalies in the lower extremities.

Entities:  

Keywords:  Fibro-Adipose Vascular Anomaly; vascular anomalies; venous malformation

Year:  2014        PMID: 25298836      PMCID: PMC4180696          DOI: 10.3400/avd.cr.14-00049

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  6 in total

1.  Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity.

Authors:  Ahmad I Alomari; Samantha A Spencer; Ryan W Arnold; Gulraiz Chaudry; James R Kasser; Patricia E Burrows; Pradeep Govender; Horacio M Padua; Brian Dillon; Joseph Upton; Amir H Taghinia; Steven J Fishman; John B Mulliken; Rebecca D Fevurly; Arin K Greene; Mary Landrigan-Ossar; Harriet J Paltiel; Cameron C Trenor; Harry P Kozakewich
Journal:  J Pediatr Orthop       Date:  2014-01       Impact factor: 2.324

2.  Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.

Authors:  J B Mulliken; J Glowacki
Journal:  Plast Reconstr Surg       Date:  1982-03       Impact factor: 4.730

3.  Venous malformations of skeletal muscle.

Authors:  Katherine D Hein; John B Mulliken; Harry P W Kozakewich; Joseph Upton; Patricia E Burrows
Journal:  Plast Reconstr Surg       Date:  2002-12       Impact factor: 4.730

4.  Toe-walking attributable to venous malformation of the calf muscle.

Authors:  Benjamin G Domb; A Jay Khanna; Sally E Mitchell; Frank J Frassica
Journal:  Clin Orthop Relat Res       Date:  2004-03       Impact factor: 4.176

5.  Giant ossified cavernous hemangioma of an extremity associated with an equinovarus deformity.

Authors:  Y C Wang; C M Jeng; D Y Wu; C Y Chang; D Resnick
Journal:  Skeletal Radiol       Date:  1998-09       Impact factor: 2.199

6.  Latent onset unilateral toe-walking secondary to hemangioma of the gastrocnemius.

Authors:  W R Klemme; P James; S R Skinner
Journal:  J Pediatr Orthop       Date:  1994 Nov-Dec       Impact factor: 2.324

  6 in total
  5 in total

Review 1.  Magnetic resonance imaging of pediatric soft-tissue vascular anomalies.

Authors:  Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2016-05-26

2.  Cryoablation of low-flow vascular malformations.

Authors:  Raja S Ramaswamy; Tatulya Tiwari; Michael D Darcy; Seung K Kim; Olaguoke Akinwande; Niloy Dasgupta; Carlos J Guevara
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

3.  Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.

Authors:  Yumiko Hori; Katsutoshi Hirose; Noriko Aramaki-Hattori; Sachi Suzuki; Robert Nakayama; Masanori Inoue; Takahiro Matsui; Masaharu Kohara; Satoru Toyosawa; Eiichi Morii
Journal:  Diagn Pathol       Date:  2020-07-25       Impact factor: 2.644

4.  Hybrid treatment of fibroadipose vascular anomaly: A case report.

Authors:  Francesco Stillo; Federica Ruggiero; Antonio De Fiores; Rita Compagna; Bruno Amato
Journal:  Open Med (Wars)       Date:  2020-09-11

5.  Management of Fibro-adipose Vascular Anomalies (FAVA) in Paediatric Practice.

Authors:  C Lipede; D Nikkhah; R Ashton; G Murphy; A M Barnacle; P A Patel; G D Smith; D M Eastwood; B Sivakumar
Journal:  JPRAS Open       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.